Literature DB >> 27230083

Validation of claims-based algorithms for gout flares.

Lindsey A MacFarlane1, Chih-Chin Liu1, Daniel H Solomon1,2, Seoyoung C Kim1,2.   

Abstract

PURPOSE: Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies of gout treatments. We developed and examined the accuracy of a claims-based algorithm to identify gout flares.
METHODS: Patients receiving care at an academic medical center between 2006 and 2010 with a diagnosis of gout or hyperuricemia were selected using an electronic medical record-Medicare claims linked dataset. Gout flares were identified by several claims-based algorithms using a diagnosis of gout combined with gout-related medication claims and/or procedure codes for arthrocentesis or joint injection. We calculated positive predictive value of these algorithms based on physician documentation of gout flare in medical record as the gold standard. Negative predictive value of the gout flare algorithm was calculated in a randomly selected subgroup of 200 patients with gout.
RESULTS: Among 3952 subjects with gout or hyperuricemia, 503 flares were identified using the medication-based algorithm, and 290 were identified using the procedure-based algorithm. The positive predictive value for gout flares ranged from 50-54% for the medication-based algorithms and 59-68% for the procedure-based algorithms. The negative predictive value of the algorithm combining both medication and procedure claims was high (85.2%).
CONCLUSION: Use of gout diagnosis codes in combination with medication dispensing or procedure codes did not appear to accurately capture gout flares in patients with gout in a claims database. However, the claims-based flare algorithm could be useful in identifying a cohort of gout patients with no flares.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  claims data; comparative effectiveness; gout; gout flare; pharmacoepidemiology

Mesh:

Year:  2016        PMID: 27230083      PMCID: PMC4930384          DOI: 10.1002/pds.4044

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  17 in total

Review 1.  Clinical practice. Gout.

Authors:  Tuhina Neogi
Journal:  N Engl J Med       Date:  2011-02-03       Impact factor: 91.245

2.  Frequency and risk factors of gout flares in a large population-based cohort of incident gout.

Authors:  Dietrich Rothenbacher; Paola Primatesta; Alberto Ferreira; Lucía Cea-Soriano; Luis A García Rodríguez
Journal:  Rheumatology (Oxford)       Date:  2011-01-12       Impact factor: 7.580

3.  Validity of gout diagnoses in administrative data.

Authors:  Leslie R Harrold; Kenneth G Saag; Robert A Yood; Ted R Mikuls; Susan E Andrade; Hassan Fouayzi; Judith Davis; K Arnold Chan; Marsha A Raebel; Ann Von Worley; Richard Platt
Journal:  Arthritis Rheum       Date:  2007-02-15

Review 4.  Treating to target: a strategy to cure gout.

Authors:  Fernando Perez-Ruiz
Journal:  Rheumatology (Oxford)       Date:  2009-05       Impact factor: 7.580

Review 5.  Assessment of outcome in clinical trials of gout--a review of current measures.

Authors:  W J Taylor; H R Schumacher; J A Singh; R Grainger; N Dalbeth
Journal:  Rheumatology (Oxford)       Date:  2007-07-24       Impact factor: 7.580

6.  Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?

Authors:  Eric Q Wu; Pankaj A Patel; Reema R Mody; Andrew P Yu; Kevin E Cahill; Jackson Tang; Eswar Krishnan
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

7.  Economic burden of gouty arthritis attacks for employees with frequent and infrequent attacks.

Authors:  Wendy Lynch; Wing Chan; Nathan Kleinman; L M Andrews; Anthony M Yadao
Journal:  Popul Health Manag       Date:  2012-10-31       Impact factor: 2.459

8.  Using natural language processing and machine learning to identify gout flares from electronic clinical notes.

Authors:  Chengyi Zheng; Nazia Rashid; Yi-Lin Wu; River Koblick; Antony T Lin; Gerald D Levy; T Craig Cheetham
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-11       Impact factor: 4.794

9.  Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.

Authors:  Robert Jackson; Aki Shiozawa; Erin K Buysman; Aylin Altan; Stephanie Korrer; Hyon Choi
Journal:  BMJ Open       Date:  2015-06-24       Impact factor: 2.692

10.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

View more
  5 in total

1.  Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Authors:  Jelena M Pavlovic; Justin S Yu; Stephen D Silberstein; Michael L Reed; Steve H Kawahara; Robert P Cowan; Firas Dabbous; Karen L Campbell; Anand R Shewale; Riya Pulicharam; Jonathan W Kowalski; Hema N Viswanathan; Richard B Lipton
Journal:  Cephalalgia       Date:  2019-03-09       Impact factor: 6.292

2.  Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study.

Authors:  Michael Fralick; Sarah K Chen; Elisabetta Patorno; Seoyoung C Kim
Journal:  Ann Intern Med       Date:  2020-01-14       Impact factor: 25.391

3.  Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.

Authors:  Edoardo Cipolletta; Laila J Tata; Georgina Nakafero; Anthony J Avery; Mamas A Mamas; Abhishek Abhishek
Journal:  JAMA       Date:  2022-08-02       Impact factor: 157.335

4.  Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan.

Authors:  Toshiki Fukasawa; Hayato Takahashi; Norin Kameyama; Risa Fukuda; Shihori Furuhata; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

5.  The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Stephen P Juraschek; Lara M Simpson; Barry R Davis; Robert H Shmerling; Jennifer L Beach; Anthony Ishak; Kenneth J Mukamal
Journal:  J Hypertens       Date:  2020-05       Impact factor: 4.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.